Wayne Rackoff

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

Matthew R. Smith, Fred Saad, Simon Chowdhury et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Randomized Phase III Study of Pegylated Liposomal Doxorubicin Plus Bortezomib Compared With Bortezomib Alone in Relapsed or Refractory Multiple Myeloma: Combination Therapy Improves Time to Progression

Robert Z. Orlowski, Arnon Nagler, Pieter Sonneveld et al. · Journal of Clinical Oncology · 2007 · 644 citations · Full text

Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer

Alan N. Gordon, Margaret Tonda, Steven Sun et al. · Gynecologic Oncology · 2004 · 430 citations

Pegylated Liposomal Doxorubicin, Medicine, Cancer Management +8

Predicting the risk of bacteremia in childen with fever and neutropenia.

Wayne Rackoff, R Gonin, Caroline O Robinson et al. · Journal of Clinical Oncology · 1996 · 227 citations

Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies

Jörge E. Cortes, Maher Albitar, Deborah A. Thomas et al. · Blood · 2003 · 209 citations